Tenders in Pharmaceutical products

Posebno skupi lijekovi (koji nisu obuhvaćeni ZN) - 1. dio

OPĆA BOLNICA ZADAR, Zadar

Nabava lijekova

DOM ZDRAVLJA SPLITSKO-DALMATINSKE ŽUPANIJE, Split

NHS National Framework for Lenvatinib

NHS England

Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months) Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lijek denosumab - iznimna žurnost (u vrijednosti od 7.779,60 EUR bez PDV-a)

Klinički bolnički centar Rijeka, Rijeka

Lijekovi -inovativna onkološka terapija

ZU KANTONALNA BOLNICA "DR. IRFAN LJUBIJANKIĆ" BIHAĆ

Ostali lijekovi (koji nisu obuhvaćeni ZN) - 2. dio

OPĆA BOLNICA ZADAR, Zadar

Lijekovi alergeni za prick test i alergijsku imunoterapiju - iznimna žurnost

Klinički bolnički centar Rijeka, Rijeka

Lijekovi relugoliks, bisoprolol - iznimna žurnost (u vrijednosti od 2.333,01 EUR bez PDV-a)

Klinički bolnički centar Rijeka, Rijeka

Lijekovi digoksin, klotrimazol, aminofilin, montelukast, tikagrelor - iznimna žurnost (u vrijednosti od 3.656,45 EUR bez PDV-a)

Klinički bolnički centar Rijeka, Rijeka

Lijekovi sildenafil, eritropoetin theta, doksorubicin, izotretinoin, klindamicin, pioglitazon + glimepirid, dinoproston, acetilcistein, solifenacin, prokarbazin, mikofenolat-natrij, eptifibatid, tiotepa, tikagrelor - iznimna žurnost

Klinički bolnički centar Rijeka, Rijeka

NHS National Framework for the supply and treatment of Blood Disorders

NHS England

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - January 2028 Offer reference number: CM/PHS/26/5749 Period of framework: 1 January 2028 to 31 December 2029 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England. The commencement of procurement and award of any subsequent contract will be subject to budgetary approval.

Lijekovi raznih skupina po ATC kodu za potrebe KCUS-a I/14/2026 (dio skupine A, B, C, D, G i H)

UNIVERZITETSKI KLINIČKI CENTAR SARAJEVO - UKCS

Lijekovi na listama HZZO-a koji imaju generičke paralele i Ostali lijekovi

KLINIKA ZA INFEKTIVNE BOLESTI DR. FRAN MIHALJEVIĆ, Grad Zagreb

Lijekovi fingolimod, oksazepam, klotrimazol, salmeterol + flutikazon, tiotropij bromid, mesalazin, klonidin - iznimna žurnost (u vrijednosti od 20.774,30 EUR bez PDV-a)

Klinički bolnički centar Rijeka, Rijeka

NHS National Framework for Abatacept Injection

NHS England

Project title: NHS National Framework for Abatacept Injection Offer reference number: CM/TNS/26/5764 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net

NHS National Framework for Cladribine tablets

NHS England

Project title: NHS National Framework for Cladribine tablets Offer reference number: CM/TNS/26/5765 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net

NHS National Framework for Trastuzumab Subcutaneous Injection

NHS England

Project title: NHS National Framework for Trastuzumab Subcutaneous Injection Offer reference number: CM/TNS/26/5762 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net

NHS National Framework for Vedolizumab Injection

NHS England

Project title: NHS National Framework for Vedolizumab Injection Offer reference number: CM/TNS/26/5763 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net

NHS National Framework for Ivacaftor

NHS England

Project title: NHS National Framework for Ivacaftor Offer reference number: CM/TNS/26/5766 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net

Generic Drugs - Tablets and Capsules 2

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

This is a contract for the provision of Tablets and Capsules Drugs

NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg

NHS England

Project title: NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg Offer reference number: CM/TNS/26/5744 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5744 Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg Lot 1 LNW 1 February 2027 to 31 October 2028 (21 months) Lot 2 DNE & SOFE 1 February 2027 to 31 October 2028 (21 months) Lot 3 DNW & MAE 1 February 2027 to 31 October 2028 (21 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Лекови ван листе лекова -Блинатумомаб

ИНСТИТУТ ЗА ЗДРАВСТВЕНУ ЗАШТИТУ МАЈКЕ И ДЕТЕТА СРБИЈЕ "ДР ВУКАН ЧУПИЋ", БЕОГРАД, ПИБ: 100136676

Lijekovi feksofenadin, buprenorfin, kalij-klorid - iznimna žurnost (u vrijednosti od 1.524,84 EUR bez PDV-a)

Klinički bolnički centar Rijeka, Rijeka